Table 2

The serum levers of apoE and other cytokines [pg/ml, M (Q1, Q3)]
Items SLE patients Controls
Pre-treatment Post-treatment
N 40 40 40
ApoE 18.31 (13.09, 45.37)*# 12.95 (8.03, 30.50)& 8.10 (5.94, 10.81)
IL-6 0.86 (0.70, 1.72)*# 0.72 (0.58, 1.18) 0.67 (0.51, 0.82)
IFN-<a onClick="popup('http://www.diagnosticpathology.org/content/8/1/175/mathml/M2','MathML',630,470);return false;" target="_blank" href="http://www.diagnosticpathology.org/content/8/1/175/mathml/M2">View MathML</a> 41.06 (33.25, 118.51)*# 33.85 (17.00, 56.08) 34.61 (29.12, 43.23)
IL-10 39.35 (31.94, 92.33)*# 33.85 (17.33, 58.80) 31.82 (23.46, 44.48)

Note: *, p < 0.05, SLE (pre-treatment) compared with normal controls; #, p < 0.05, SLE (pre-treatment) compared with SLE (post-treatment); &, p < 0.05, SLE (post-treatment) compared with normal controls.

Song et al.

Song et al. Diagnostic Pathology 2013 8:175   doi:10.1186/1746-1596-8-175

Open Data